BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 17332680)

  • 1. Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis.
    Simon TG; Trejo MEP; McClelland R; Bradley R; Blaha MJ; Zeb I; Corey KE; Budoff MJ; Chung RT
    Int J Cardiol; 2018 May; 259():198-204. PubMed ID: 29579601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-Linked Lymphoproliferative Syndrome and Common Variable Immunodeficiency May Not Be Differentiated by SH2D1A and XIAP/BIRC4 Genes Sequence Analysis.
    Gulez N; Aksu G; Berdeli A; Karaca N; Tanrıverdi S; Kutukculer N; Azarsiz E
    Case Rep Med; 2011; 2011():121258. PubMed ID: 21541208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT).
    Saremi A; Anderson RJ; Luo P; Moritz TE; Schwenke DC; Allison M; Reaven PD;
    Atherosclerosis; 2009 Apr; 203(2):610-4. PubMed ID: 18804762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1).
    Kaur S; Wang F; Venkatraman M; Arsura M
    J Biol Chem; 2005 Nov; 280(46):38599-608. PubMed ID: 16157589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
    Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induced by trimethyltin chloride in human neuroblastoma cells SY5Y is regulated by a balance and cross-talk between NF-κB and MAPKs signaling pathways.
    Qing Y; Liang Y; Du Q; Fan P; Xu H; Xu Y; Shi N
    Arch Toxicol; 2013 Jul; 87(7):1273-85. PubMed ID: 23423712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori.
    Lu H; Wu JY; Kudo T; Ohno T; Graham DY; Yamaoka Y
    Mol Biol Cell; 2005 Oct; 16(10):4954-66. PubMed ID: 16030249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways.
    Eberhardt W; Huwiler A; Beck KF; Walpen S; Pfeilschifter J
    J Immunol; 2000 Nov; 165(10):5788-97. PubMed ID: 11067938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Cell Death and Immunity by XIAP.
    Jost PJ; Vucic D
    Cold Spring Harb Perspect Biol; 2020 Aug; 12(8):. PubMed ID: 31843992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-Induced Endothelial Vascular Injury: A Review of Possible Mechanisms.
    Venkatesulu BP; Mahadevan LS; Aliru ML; Yang X; Bodd MH; Singh PK; Yusuf SW; Abe JI; Krishnan S
    JACC Basic Transl Sci; 2018 Aug; 3(4):563-572. PubMed ID: 30175280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked inhibitor of apoptosis protein regulates human interleukin-6 in umbilical vein endothelial cells via stimulation of the nuclear factor-kappaB and MAP kinase signaling pathways.
    Resch U; Winsauer G; Hofer-Warbinek R; de Martin R
    Pharmacol Rep; 2006; 58 Suppl():111-7. PubMed ID: 17332680
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.